PD41: Prostate Cancer: Detection & Screening IV

Sunday, May 15, 2022

9:30 AM – 11:30 AM

Location: Room 255

Podium Session Moderator(s)

Fred Saad, MD,FRCPC

Professor and Chief of Urology
University of Montreal Hospital Center
Armando Stabile, MD

Vita-Salute San Raffaele University

Presentations:

9:30 AM – 9:40 AM

PD41-01: Detection of occult prostate adenocarcinoma using stereotactic transperineal biopsy following negative transrectal ultrasound-guided biopsies
Podium Presenter: Russell Maxwell, MD – Hospital of the University of Pennsylvania
9:40 AM – 9:50 AM

PD41-02: Diagnosis of Prostate cancer in men treated with 5-alpha-reducates inhibitors with Multiparametric MRI: results of a multicenter international collaboration
Podium Presenter: Ugo G. Falagario, MD – University of Foggia
9:50 AM – 10:00 AM

PD41-03: Antibiotic-Free Transperineal Prostate Biopsy: Urology's Contribution to Responsible Antimicrobial Stewardship
Podium Presenter: Jeffrey L. Ellis, MD
10:00 AM – 10:10 AM

PD41-04: Distribution of National Comprehensive Cancer Network Risk Classifications Using Magnetic Resonance Imaging-Ultrasound Fusion versus Systemic 12 core Biopsies
Podium Presenter: Ghazal Khajir, MD – Yale School of Medicine
10:10 AM – 10:20 AM

PD41-05: Biopsy Technique (Transperineal vs. Transrectal) is not Associated with Positive Surgical Margins or Perioperative Morbidity Following Radical Prostatectomy
Podium Presenter: Johnathan A. Drevik, MD
10:20 AM – 10:30 AM

PD41-06: Transperineal prostate biopsies using micro-ultrasound, MRI-guided and systematic biopsies (Madrid Protocol), an update with 482 patients
Podium Presenter: Moises Rodriguezsocarras, MD – ICUA - Clinica Cemtro
10:30 AM – 10:40 AM

PD41-07: Learning Curve for Transperineal Ultrasound/MRI Fusion Biopsy for the Detection of Prostate Cancer
Podium Presenter: Yuval Elkun, BS
10:40 AM – 10:50 AM

PD41-08: The role of micro-ultrasound among patients with a PIRADS 5 lesion at multiparametric magnetic resonance imaging
Podium Presenter: Marco Paciotti, MD
10:50 AM – 11:00 AM

PD41-09: Moving Beyond PSA: Identifying the Optimal Diagnostic Strategy to Assess Prostate Cancer Risk
Podium Presenter: Douglas Cheung, MD
11:00 AM – 11:10 AM

PD41-10: The Utility of PSA Density in Patients with PI-RADs 3 Lesions Across a Large Multi-Institutional Collaborative
Podium Presenter: Johnathan A. Drevik, MD
11:10 AM – 11:20 AM

PD41-11: Update from the PEDAL trial: A prospective single arm paired comparison of ability to diagnose and locate prostate cancer between multiparametric MRI and 18F-PSMA-PET/CT
Podium Presenter: Vy Tran
11:20 AM – 11:30 AM

PD41-12: From biopsy to diagnosis in 30 min: Remote instant prostate pathology based on artificial intelligence enhanced ultrasound (AI-US)